Model 1 | Model 2 | Model 3 | Model 4 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coef. | SE | HR | 95%CI | Coef. | SE | HR | 95%CI | Coef. | SE | HR | 95%CI | Coef. | SE | HR | 95%CI | |
No comorbidity | 1.0 (ref.) | |||||||||||||||
Hyperlipidemia | 0.092 | 0.177 | 1.09 | 0.80 to 1.50 | −0.103 | 0.147 | 0.90 | 0.66 to 1.24 | −0.101 | 0.151 | 0.90 | 0.66 to 1.24 | −0.103 | 0.155 | 0.90 | 0.66 to 1.24 |
DM | 1.191 | 0.349 | 3.29 | 2.67 to 4.05 | 0.608 | 0.208 | 1.84 | 1.47 to 2.29 | 0.607 | 0.209 | 1.84 | 1.47 to 2.29 | 0.621 | 0.217 | 1.86 | 1.49 to 2.32 |
DM plus hyperlipidemia | 1.389 | 0.534 | 4.01 | 3.09 to 5.21 | 0.667 | 0.282 | 1.94 | 1.46 to 2.57 | 0.662 | 0.300 | 1.94 | 1.46 to 2.57 | 0.656 | 0.313 | 1.93 | 1.45 to 2.56 |
P for trend | < 0.001 | < 0.001 | < 0.001 | < 0.001 |